Annual Drug Patent Expirations for CAYSTON
Cayston is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has forty-four patent family members in twenty-one countries.
The generic ingredient in CAYSTON is aztreonam. One supplier is listed for this compound. Additional details are available on the aztreonam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
